Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Review Series - Recent Advances in the Management of Secondary Hypertension

Blood pressure management in patients receiving renal replacement therapy

Hypertension Research volume 44, pages 7–12 (2021)Cite this article

Abstract

Hypertension is the most common complication of kidney disease, diabetes, and other cardiovascular diseases. In addition, it is a critical factor in the progression of these diseases, and hence, blood pressure management is highly recommended worldwide, in accordance with the major guidelines. However, there are two blind spots in the management system: one concerns patients with cancer, and the other concerns patients receiving renal replacement therapy. End-stage renal failure is the final stage of hypertension, and nephrologists usually treat hypertension in both nondialysis patients and dialysis patients. Nephrologists first attempt to manage the blood pressure of dialysis patients using the same method employed for nondialysis patients, i.e., by deciding on a target blood pressure at the clinic. However, this is exceedingly difficult because dialysis patients have lost their most important body-fluid autoregulatory mechanism and have varying body weights during the dialysis session. Moreover, numerous lines of evidence and clinicians’ observations have suggested that hypotension during a dialysis session leads to an unfavorable prognosis. However, when the target blood pressure is increased to avoid hypotension during a dialysis session, the risk of atherosclerosis and bleeding complications will be increased. Many nephrologists may feel unsure of choosing a target blood pressure using traditional methods. Recently, home blood pressure and average blood pressure have become new indices of blood pressure management. We believe that further advancements of this old and important theme will be possible with new technologies and big-data analytical methods.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, et al. Annual dialysis data report 2017, JSDT Renal Data Registry. Ren Replacement Ther. 2019;5:53.

    Article  Google Scholar 

  2. Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H, Kobayashi S, et al. Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis. Ther Apheresis Dial. 2012;16:387–435.

    Article  Google Scholar 

  3. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)2014 Guideline for Management of High Blood Pressure2014 Guideline for Management of High Blood Pressure. JAMA. 2014;311:507–20.

    Article  CAS  Google Scholar 

  4. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.

    Article  CAS  Google Scholar 

  5. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253.

    Article  Google Scholar 

  6. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertension Res. 2019;42:1235–481.

    Article  Google Scholar 

  7. Moriya H, Ohtake T, Kobayashi S. Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on haemodialysis. Nephrol Dial Transpl. 2007;22:1198–204.

    Article  Google Scholar 

  8. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, et al. Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol. 2008;3:416–22.

    Article  Google Scholar 

  9. Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, et al. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transpl. 2017;32:620–40.

    Article  Google Scholar 

  10. Inaba M, Karaboyas A, Akiba T, Akizawa T, Saito A, Fukuhara S, et al. Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study. Hemodial Int. 2014;18:607–15.

    Article  Google Scholar 

  11. Bansal N, McCulloch CE, Lin F, Alper A, Anderson AH, Cuevas M, et al. Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2017;70:435–43.

    Article  CAS  Google Scholar 

  12. Hannedouche T, Roth H, Krummel T, London GM, Jean G, Bouchet JL, et al. Multiphasic effects of blood pressure on survival in hemodialysis patients. Kidney Int. 2016;90:674–84.

    Article  Google Scholar 

  13. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66:1212–20.

    Article  Google Scholar 

  14. Chou JA, Streja E, Nguyen DV, Rhee CM, Obi Y, Inrig JK, et al. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients. Nephrol Dial Transplant. 2018;33:149–59.

  15. Huang WH, Hsu CW, Hu CC, Yen TH, Weng CH. Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study. Ther Clin Risk Manag. 2016;12:1285–92.

    Article  CAS  Google Scholar 

  16. Sands JJ, Usvyat LA, Sullivan T, Segal JH, Zabetakis P, Kotanko P, et al. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int. 2014;18:415–22.

    Article  Google Scholar 

  17. Yotsueda R, Taniguchi M, Tanaka S, Eriguchi M, Fujisaki K, Torisu K, et al. Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: the Q-Cohort Study. Am J Kidney Dis. 2017;70:84–92.

    Article  Google Scholar 

  18. Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O, et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol. 2017;28:2491–7.

    Article  CAS  Google Scholar 

  19. Shoji T, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:1112–20.

    Article  CAS  Google Scholar 

  20. Japanese Society for Dialysis Therapy. Dialysis prescription and patient survival [in Japanese]. in Illustrated version of an overview of regular dialysis treatment in Japan (as of 31 December 2009). Japanese Society for Dialysis Therapy: Tokyo; 2010. p. 66–89.

  21. Agarwal R, Alborzi P, Satyan S, Light RP. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension. 2009;53:500–7.

    Article  CAS  Google Scholar 

  22. Agarwal R, Sinha AD, Pappas MK, Abraham TN, Tegegne GG. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transpl. 2014;29:672–81.

    Article  CAS  Google Scholar 

  23. Fravel MA, Bald E, Fraer M. Antihypertensive Agents in the Dialysis Patient. Curr Hypertens Rep. 2019;21:5.

    Article  Google Scholar 

  24. Working Group Committee for the Preparation of Guidelines for Peritoneal Dialysis JSfDT. 2009 Japanese Society for Dialysis Therapy Guidelines for Peritoneal Dialysis. Ther Apheresis Dial. 2010;14:489–504.

    Article  Google Scholar 

  25. Afshinnia F, Zaky ZS, Metireddy M, Segal JH. Reverse Epidemiology of Blood Pressure in Peritoneal Dialysis Associated with Dynamic Deterioration of Left Ventricular Function. Perit Dial Int. 2016;36:154–62.

    Article  CAS  Google Scholar 

  26. Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell D, et al. Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis. 2009;53:70–8.

    Article  Google Scholar 

  27. Cosio FG, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM, Mitchell L, et al. Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients. Kidney Int. 2001;59:1158–64.

    Article  CAS  Google Scholar 

  28. Taler SJ, Textor SC, Canzanello VJ, Schwartz L. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf. 1999;20:437–49.

    Article  CAS  Google Scholar 

  29. Okada H, Yasuda Y, Kashihara N, Asahi K, Ito T, Kaname S, et al. Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018. Clin Exp Nephrol. 2019;23:1–15.

    Article  Google Scholar 

  30. Hillebrand U, Suwelack BM, Loley K, Lang D, Reuter S, Amler S, et al. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients. Transpl Int. 2009;22:1073–80.

    Article  CAS  Google Scholar 

  31. Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transpl. 2005;5:2725–31.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Tokyo Medical University, Tokyo, Japan

    Yoshihiko Kanno

Authors
  1. Yoshihiko Kanno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshihiko Kanno.

Ethics declarations

Conflict of interest

The author received honoraria and/or fees for the promotional materials from KyowaKirin, Chugai Pharmaceutical, Kissei Pharmaceutical, and Fuji Yakuhin and received research funding from KyowaKirin and Chugai Pharmaceutical.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanno, Y. Blood pressure management in patients receiving renal replacement therapy. Hypertens Res 44, 7–12 (2021). https://doi.org/10.1038/s41440-020-00563-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-020-00563-4

Keywords

This article is cited by

Search

Advanced search

Quick links